Biotika A.S. Logo

Biotika A.S.

A biotechnology company that manufactures APIs for human and veterinary applications.

BSL | BSSE

Overview

Corporate Details

ISIN(s):
SK1120004009
LEI:
097900BGMP0000060091
Country:
Slovakia
Address:
566, 976 13 Slovenská Ľupča

Description

Biotika A.S. is a biotechnology company that manufactures Active Pharmaceutical Ingredients (APIs) for human and veterinary applications. With a history of over 70 years, the company specializes in the biotechnological production of APIs, with its primary products being penicillin and polymyxin B sulfate. Biotika also offers contract manufacturing services, including the transfer and scaling of products from laboratory to commercial production. Additionally, the company engages in research and development activities within the field of biotechnology.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-22 08:14
Oznámenie o konaní MVZ dňa 21.1.2026
Slovak 94.0 KB
2025-06-24 11:04
Uznesenia z RVZ Biotika a.s. z 18.6.2025
Slovak 85.4 KB
2025-05-16 08:20
Oznámenie o konaní VZ dňa 18.6.2025
Slovak 126.3 KB
2025-04-30 11:55
Inzercia v HN Ročná finančná správa 2024
Slovak 631.5 KB
2025-01-30 15:19
Uznesenia z MVZ Biotika a.s. z 29.1.2025
Slovak 178.9 KB
2024-12-20 13:16
Oznámenie o konaní MVZ dňa 29.1.2025
Slovak 51.0 KB
2024-12-19 08:50
Zmena podielu na hlasovacích právach emitenta
Slovak 1.2 MB
2024-04-12 13:57
Uznesenia z RVZ Biotika a.s. z 11.4.2024
Slovak 135.0 KB
2024-03-11 15:24
Oznámenie o konaní VZ dňa 11.4.2024
Slovak 153.0 KB
2024-01-31 12:08
Biotika zmeny v podieloch na hlasovacích právach
Slovak 157.3 KB
2024-01-18 11:48
Polročná finančná správa 2023 doplnenie
Slovak 303.6 KB
2023-08-23 13:49
Oznámenie o zmene hlasovacích práv
Slovak 60.2 KB
2023-08-22 14:56
Oznámenie o nadobudnutí hlasovacích práv - Vinohrady Investments, a.s.
Slovak 525.0 KB
2023-08-22 14:55
Oznámenie o prevode hlasovacích práv - BIO S.L., a.s.
Slovak 511.8 KB
2023-03-31 13:54
Uznesenia z RVZ Biotika a.s. z 30.3.2023
Slovak 596.2 KB

Automate Your Workflow. Get a real-time feed of all Biotika A.S. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Biotika A.S.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Biotika A.S. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Access Bio, Inc. Logo
Develops and manufactures in vitro diagnostic solutions for infectious diseases.
United States of America
950130
ACHIEVE LIFE SCIENCES, INC. Logo
A late-stage pharmaceutical company developing a treatment for nicotine dependence.
United States of America
ACHV
AC Immune SA Logo
Biopharmaceutical firm developing precision medicine for neurodegenerative diseases.
United States of America
ACIU
Aclaris Therapeutics, Inc. Logo
Clinical-stage biopharmaceutical company developing drugs for immuno-inflammatory diseases.
United States of America
ACRS
Acrivon Therapeutics, Inc. Logo
Clinical-stage biopharma using proteomics to develop precision oncology therapies.
United States of America
ACRV
Acticor Biotech Logo
Develops treatments for thrombotic diseases, focusing on acute ischemic stroke.
France
ALACT
Actinium Pharmaceuticals, Inc. Logo
Clinical-stage company developing targeted radiotherapies for difficult-to-treat cancers.
United States of America
ATNM
ACTUATE THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing therapies for cancers with high unmet needs.
United States of America
ACTU
AcuCort AB Logo
Develops user-friendly drug formulations for severe and acute allergic reactions.
Sweden
ACUC
Acumen Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing targeted therapies for Alzheimer's disease.
United States of America
ABOS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.